Long-term effect of pegylated liposomal doxorubicin in recurrent platinum-resistant ovarian cancer: а clinical case by I. A. Pokataev, A. S. Tyulyandina, L. V. Chitia, S. A. Tyulyandin

Get full text

Prospects of therapeutic action on FGFR signaling pathway by M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin

Get full text

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases by A. D. Petrova, M. B. Stenina, L. V. Manzyuk, N. V. Lyubimova, S. A. Tyulyandin

Get full text

Tamoxifen Molecular Targets Different From Estrogen Receptors by T. A. Bogush, E. A. Dudko, E. A. Bogush, B. E. Polotsky, S. A. Tyulyandin, M. I. Davydov

Get full text

The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer by T. A. Bogush, E. A. Dudko, E. A. Bogush, B. E. Polotsky, S. A. Tyulyandin, M. I. Davydov

Get full text

ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs by T. A. Bogush, A. S. Popova, E. A. Dudko, E. A. Bogush, A. S. Tyulyandina, S. A. Tyulyandin, M. I. Davydov

Get full text

The Quantitative Indices of ERCC1 Expression in Serous Ovarian Cancer Tissue and the Efficacy of First-Line Platinum-Based Chemotherapy by T. A. Bogush, M. B. Stenina, E. A. Bogush, V. T. Zarkua, S. A. Kalyuzhny, I. A. Mamichev, A. S. Tyulyandina, S. A. Tyulyandin

Get full text

The first experience with intraabdominal chemotherapy in patients with disseminated ovarian cancer by A. S. Tyulyandina, V. Yu. Buidenok, K. I. Zhordania, I. V. Panichenko, V. V. Kuznetsov, M. B. Stenina, S. A. Tyulyandin

Get full text

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery by L. N. Lyubchenko, Ye. I. Bateneva, I. K. Vorotnikov, S. M. Portnoy, O. V. Krokhina, V. A. Sobolevskiy, L. G. Zhukova, V. A. Khaylenko, S. A. Tyulyandin

Get full text